142 related articles for article (PubMed ID: 20801436)
41. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection.
Smeenk JM; Sweep FC; Zielhuis GA; Kremer JA; Thomas CM; Braat DD
Fertil Steril; 2007 Jan; 87(1):223-6. PubMed ID: 17081531
[TBL] [Abstract][Full Text] [Related]
42. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study.
Demirol A; Gurgan T
Fertil Steril; 2009 Aug; 92(2):481-5. PubMed ID: 18990368
[TBL] [Abstract][Full Text] [Related]
43. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
[TBL] [Abstract][Full Text] [Related]
44. Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.
Malmusi S; La Marca A; Giulini S; Xella S; Tagliasacchi D; Marsella T; Volpe A
Fertil Steril; 2005 Aug; 84(2):402-6. PubMed ID: 16084881
[TBL] [Abstract][Full Text] [Related]
45. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
[TBL] [Abstract][Full Text] [Related]
46. Role of gonadotropin-releasing hormone antagonists in poor responders.
Mahutte NG; Arici A
Fertil Steril; 2007 Feb; 87(2):241-9. PubMed ID: 17113088
[TBL] [Abstract][Full Text] [Related]
47. "Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization.
Gleicher N; Barad D
Fertil Steril; 2006 Dec; 86(6):1621-5. PubMed ID: 17074322
[TBL] [Abstract][Full Text] [Related]
48. IVF versus ICSI in sibling oocytes from patients with polycystic ovarian syndrome: a randomized controlled trial.
Hwang JL; Seow KM; Lin YH; Hsieh BC; Huang LW; Chen HJ; Huang SC; Chen CY; Chen PH; Tzeng CR
Hum Reprod; 2005 May; 20(5):1261-5. PubMed ID: 15705619
[TBL] [Abstract][Full Text] [Related]
49. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
[TBL] [Abstract][Full Text] [Related]
50. Ongoing twin pregnancy after rescue intracytoplasmic sperm injection of unfertilized abnormal oocytes.
Esfandiari N; Claessens EA; Burjaq H; Gotlieb L; Casper RF
Fertil Steril; 2008 Jul; 90(1):199.e5-7. PubMed ID: 18329024
[TBL] [Abstract][Full Text] [Related]
51. [GnRH antagonists in natural cycles].
Frydman R
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S46-9. PubMed ID: 15643689
[TBL] [Abstract][Full Text] [Related]
52. [Idiopathic subfertility: pregnancy rate after IVF treatment in minimally stimulated monofollicular ovarian cycle].
Berg FD; Seifert-Klauss V
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):127-9. PubMed ID: 7665058
[TBL] [Abstract][Full Text] [Related]
53. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
Jayaprakasan K; Hopkisson J; Campbell B; Johnson I; Thornton J; Raine-Fenning N
BJOG; 2010 Jun; 117(7):853-62. PubMed ID: 20353458
[TBL] [Abstract][Full Text] [Related]
54. The effectiveness of transdermal testosterone gel 1% (androgel) for poor responders undergoing in vitro fertilization.
Doan HT; Quan LH; Nguyen TT
Gynecol Endocrinol; 2017 Dec; 33(12):977-979. PubMed ID: 28562099
[TBL] [Abstract][Full Text] [Related]
55. The use of aromatase inhibitors in in vitro fertilization.
Garcia-Velasco JA
Fertil Steril; 2012 Dec; 98(6):1356-8. PubMed ID: 23062732
[TBL] [Abstract][Full Text] [Related]
56. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.
; Alviggi C; Andersen CY; Buehler K; Conforti A; De Placido G; Esteves SC; Fischer R; Galliano D; Polyzos NP; Sunkara SK; Ubaldi FM; Humaidan P
Fertil Steril; 2016 Jun; 105(6):1452-3. PubMed ID: 26921622
[No Abstract] [Full Text] [Related]
57. Testosterone for Poor Ovarian Responders: Lessons From Ovarian Physiology.
Polyzos NP; Davis SR; Drakopoulos P; Humaidan P; De Geyter C; Vega AG; Martinez F; Evangelou E; van de Vijver A; Smitz J; Tournaye H; Barri P;
Reprod Sci; 2018 Jul; 25(7):980-982. PubMed ID: 27489169
[TBL] [Abstract][Full Text] [Related]
58. Ovarian Features after 2 Weeks, 3 Weeks and 4 Weeks Transdermal Testosterone Gel Treatment and Their Associated Effect on IVF Outcomes in Poor Responders.
Kim CH; Ahn JW; Moon JW; Kim SH; Chae HD; Kang BM
Dev Reprod; 2014 Sep; 18(3):145-52. PubMed ID: 25949183
[TBL] [Abstract][Full Text] [Related]
59. Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF).
Kamble L; Gudi A; Shah A; Homburg R
Hum Fertil (Camb); 2011 Dec; 14(4):230-45. PubMed ID: 21970738
[TBL] [Abstract][Full Text] [Related]
60. Controlled ovarian stimulation and IVF pregnancy in a trisomy X carrier with associated hypogonadotropic hypogonadism.
Massarotti C; Fiorio P; Gastaldi R; Rosaia De Santis L; Pastorino D; Remorgida V; Anserini P
Gynecol Endocrinol; 2017 Oct; 33(10):763-765. PubMed ID: 28485664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
